Vasodilatory Shock
A form of distributive shock characterized by severe vasodilation leading to hypotension despite adequate intravascular volume. Includes septic shock, post-cardiotomy shock, and other causes of catecholamine-resistant hypotension.
Quick Answer
What it is
A form of distributive shock characterized by severe vasodilation leading to hypotension despite adequate intravascular volume. Includes septic shock, post-cardiotomy shock, and other causes of catecholamine-resistant hypotension.
Key findings
- Grade A: Blood Pressure Support (Vasopressin (Vasostrict/Pitressin))
- Grade A: Norepinephrine Sparing (Vasopressin (Vasostrict/Pitressin))
- Grade A: Mortality (Less Severe Sepsis) (Vasopressin (Vasostrict/Pitressin))
Safety
No specific caution or interaction language was detected in the current summary/outcome notes.
ℹ️ Quick Facts
Quick Facts: Vasodilatory Shock
- Supplements Studied:1
1 supps · 4 outcomes
Detailed Outcomes
A
Blood Pressure Support
FDA-approved for maintaining blood pressure in vasodilatory shock. MAP significantly higher at 24h with AVP+NE vs NE alone.
large↑Improves
A
Norepinephrine Sparing
Significantly reduces norepinephrine dose requirements at 24 and 48 hours. Allows weaning of catecholamines.
large↓Improves
A
Mortality (Less Severe Sepsis)
VASST trial: 28-day mortality 26.5% vs 35.7% (p=0.05) in less severe septic shock. No benefit in more severe shock.
moderate↓Improves
A
Hemodynamic Stabilization
Heart rate lower at 24-48h with AVP. Effective even in catecholamine-resistant vasodilatory shock.
large↑Improves